Cytokinetics (CYTK) Interest Expenses (2012 - 2025)

Cytokinetics (CYTK) has reported Interest Expenses for 16 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Interest Expenses fell 83.57% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $19.9 million (down 51.23% YoY), while the FY2025 annual figure was $305.4 million, down 57.16% from the prior year.
• Interest Expenses rose to $1.6 million in Q1 2026 per CYTK's latest filing, from -$2.4 million in the prior quarter.
• Across five years, Interest Expenses topped out at $22.1 million in Q3 2025 and bottomed at -$10.8 million in Q4 2023.
• Historically, Interest Expenses has averaged $7.3 million across 5 years, with a median of $7.1 million in 2023.
• Annual changes were most pronounced in 2022 — Interest Expenses surged 190.24% — and 2023, when it plunged 178.27%.
• Cytokinetics' Interest Expenses stood at $13.9 million in 2022, then slumped by 178.27% to -$10.8 million in 2023, then jumped by 187.76% to $9.5 million in 2024, then plunged by 125.27% to -$2.4 million in 2025, then surged by 165.9% to $1.6 million in 2026.
• Business Quant data shows CYTK's Interest Expenses at $1.6 million in Q1 2026, -$2.4 million in Q4 2025, and $22.1 million in Q3 2025.